Patients with locally advanced, inoperable squamous cell carcinoma of the head and neck were offered three courses of cisplatin and 96-h 5-fluorouracil (5-FU) infusion. Subsequent therapy included surgery when feasible, irradiation therapy, and a maintenance program of methotrexate (MTX)-5-FU. Thirt
Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas
โ Scribed by Atif M. Hussein; Pasquale Benedetto; Kasi S. Sridhar
- Book ID
- 102668483
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 536 KB
- Volume
- 65
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
Six men with either recurrent (n = 4) or unresectable (n = 2) squamous cell carcinoma of the penis (n = 5) and urethra (n = 1) received chemotherapy with cisplatin intravenously at a dose of 100 mg/m2. This was followed 24 hours later by a continuous intravenous infusion of 5-fluorouracil(5-FU) at a dose of 960 mg/m2/d for five days every 3 to 4 weeks. There was universal alopecia. The other toxicities were mild and consisted of mucositis, nausea, vomiting, reversible creatininemia, and transient azotemia. After chemotherapy, five patients had a clinical partial response and one had a complete response. Of the five patients with no metastases, three had residual unresectable tumors. These three patients received radiation and survived for 6,8, and 20 mouths after the start of chemotherapy. The other two patients were rendered disease-free by surgery. The first patient, who was a partial responder to chemotherapy, survived for 26 months. The second patient, who was a clinical complete responder, had excision of microscopic disease and is disease-free at 32+ months after the start of chemotherapy. This is the first article to report that the combination of cisplatin and 5-FU is active in penile and urethral carcinomas. After chemotherapy, surgery may be useful in selected patients to accurately assess response and excise localized residual tumors. Patients rendered tumor-free may achieve long-term survival.
Cancer 65433-438. 1990.
ARCINOMA OF THE PENIS represents approximately
C 2% of all cancers of the male genital organs' and accounts for 0.4% to 0.6% of all malignancies in US men.2 Poor hygiene and chronic exposure to smegma, especially in the absence of circumcision, may predispose to penile cancer (usually a squamous cell ~a r c i n o m a ) . ~ The prognosis depends on the stage of the disease. In the absence of inguinal or pelvic lymphadenopathy, SO% to 70% of the patients will be cured by local therapies (e.g., surgery or radiation therapy). However, the 5-year survival rate is 10% to 30% in patients with lymph node involvement, despite local t h e r a p i e ~. ~-~
The psychologic complication of both surgery and radiation therapy is significant in all stages. In later stages, the psychologic complication is compounded by a 3% mortality rate associated with bilateral inguinal and pelvic lymphadenectomy.
Chemotherapy, either alone or in combination with a local therapy, has been used in penile carcinoma to decrease the complication and improve the local control and survival. The choice of chemotherapy is controversial as the literature (Tables and) is difficult to interpret
๐ SIMILAR VOLUMES
Seven patients with advanced locoregional or metastatic squamous cell carcinoma of the skin were treated with cis-daimminedichloroplatin (cisplatin) and 5fluorouracil(5-FU). Responses were seen in six of seven patients (three partial responses [PR] and three complete responses [CR]). One patient is